Feedback of Antibiotic Prescribing in Primary Care (FAPPC) trial: results of a real-world cluster randomized controlled trial in Scotland, UK.


Journal

The Journal of antimicrobial chemotherapy
ISSN: 1460-2091
Titre abrégé: J Antimicrob Chemother
Pays: England
ID NLM: 7513617

Informations de publication

Date de publication:
28 11 2022
Historique:
received: 17 02 2022
accepted: 30 08 2022
pubmed: 30 9 2022
medline: 1 12 2022
entrez: 29 9 2022
Statut: ppublish

Résumé

To evaluate the effect of general practice-level prescribing feedback on antibiotic prescribing in a real-world pragmatic cluster randomized controlled trial. Three hundred and forty general practices in four territorial Health Boards in NHS Scotland were randomized in Quarter 1, 2016 to receive four quarterly antibiotic-prescribing feedback reports or not, from Quarter 2, 2016 to Quarter 1, 2017. Reports included different clinical topics, benchmarking against national and health board rates, and behavioural messaging with improvement actions. The primary outcome was total antibiotic prescribing rate. There were 16 secondary prescribing outcomes and 5 hospital admission outcomes (potential adverse effects of reduced prescribing). The main evaluation timepoint was 1 year after the final report (Quarter 1, 2018), with an additional evaluation in the quarter after the final report (Quarter 2, 2017). Routine administrative NHS data were used to generate the feedback reports and analyse the effects. Total antibiotic prescribing rates were lower at the main evaluation timepoint in both intervention (1.83 versus baseline 1.93 prescriptions/1000 patients/day) and control (1.90 versus baseline 1.98) practices, with no evidence of intervention effect [adjusted rate ratio (ARR) 0.98 (95% CI 0.94-1.02; P = 0.35)]. At the additional timepoint, adjusted total antibiotic prescribing rates were 1.67 and 1.73 prescriptions/1000 patients/day, with evidence of a small intervention effect, ARR 0.99 (0.98-1.00; P = 0.03). This well-designed, practice-level antibiotic-prescribing feedback had limited evidence of additional effects in the context of decreasing antibiotic prescribing and an established national stewardship programme.

Identifiants

pubmed: 36172861
pii: 6730390
doi: 10.1093/jac/dkac317
pmc: PMC9704438
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3291-3300

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.

Références

J Antimicrob Chemother. 2015 Feb;70(2):602-8
pubmed: 25326088
Implement Sci. 2010 Jul 20;5:57
pubmed: 20646275
CMAJ. 1999 Aug 24;161(4):388-92
pubmed: 10478162
Lancet. 2012 Apr 7;379(9823):1310-9
pubmed: 22357106
Drug Ther Bull. 2021 Feb;59(2):24-28
pubmed: 33509906
N Engl J Med. 2016 Mar 17;374(11):1053-64
pubmed: 26981935
Fam Med. 2000 Jan;32(1):22-9
pubmed: 10645510
Qual Health Care. 2000 Sep;9(3):159-65
pubmed: 10980076
BMJ. 1999 Feb 20;318(7182):507-11
pubmed: 10024260
Cochrane Database Syst Rev. 2017 Feb 09;2:CD003543
pubmed: 28178770
CMAJ. 2016 Feb 2;188(2):108-115
pubmed: 26573754
Br J Clin Pharmacol. 2020 Feb;86(2):250-257
pubmed: 31758595
Scand J Prim Health Care. 2003 Mar;21(1):47-51
pubmed: 12718461
Pediatrics. 2013 Apr;131(4):e1071-81
pubmed: 23478860
Fam Pract. 2021 Jul 28;38(4):373-380
pubmed: 33783497
Implement Sci. 2014 Jan 17;9:14
pubmed: 24438584
Eur J Clin Pharmacol. 2006 Feb;62(2):135-42
pubmed: 16389536
Fam Pract. 1999 Oct;16(5):495-500
pubmed: 10533946
West J Med. 1982 Nov;137(5):448-50
pubmed: 6891147
Lancet. 2016 Apr 23;387(10029):1743-52
pubmed: 26898856
Implement Sci. 2014 Oct 11;9:133
pubmed: 25304255
Cochrane Database Syst Rev. 2012 Jun 13;(6):CD000259
pubmed: 22696318
Acad Med. 2009 Sep;84(9):1217-25
pubmed: 19707060
BMJ. 2016 Aug 18;354:i4079
pubmed: 27540041
J Eval Clin Pract. 2009 Oct;15(5):807-12
pubmed: 19811593
PLoS Med. 2016 Aug 30;13(8):e1002115
pubmed: 27575599

Auteurs

Charis A Marwick (CA)

Population Health & Genomics Division, School of Medicine, University of Dundee, Dundee, UK.

Anower Hossain (A)

Institute of Statistical Research and Training, University of Dhaka, Dhaka-1000, Bangladesh.

Rita Nogueira (R)

Public Health Scotland, Edinburgh, UK.

Jacqueline Sneddon (J)

Scottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland, Glasgow, UK.

Kim Kavanagh (K)

Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK.

Marion Bennie (M)

Public Health Scotland, Edinburgh, UK.
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.

R Andrew Seaton (RA)

Scottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland, Glasgow, UK.
Infectious Diseases Unit, Queen Elizabeth University Hospital, Glasgow, UK.

Bruce Guthrie (B)

Usher Institute, University of Edinburgh, Edinburgh, UK.

William Malcolm (W)

ARHAI (Antimicrobial Resistance and Healthcare Associated Infection) Scotland, NHS National Services Scotland, Glasgow, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH